Results 131 to 140 of about 2,631 (192)

ToxPoint: The case for Equilibrative Nucleoside Transporters in current regulatory guidance. [PDF]

open access: yesToxicol Sci
Martinez-Guerrero L   +4 more
europepmc   +1 more source

Old Drug, New Science: Metformin and the Future of Pharmaceutics. [PDF]

open access: yesPharmaceutics
Caturano A   +8 more
europepmc   +1 more source

Drug-drug interactions in targeted cancer therapies: a focus on tyrosine kinase inhibitors. [PDF]

open access: yesExpert Rev Clin Pharmacol
Stromatt JC   +6 more
europepmc   +1 more source

The Effect of MATE1 Polymorphisms on Cisplatin Efficacy in the Treatment of Head and Neck Cancer

open access: yesInternational Journal of Radiation Oncology*Biology*Physics, 2018
Mahler, M   +8 more
openaire   +3 more sources

Disruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity.

open access: yesDisruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity.
Multidrug and toxin extrusion 1 (MATE1/SLC47A1) is expressed in the brush-border membrane of renal proximal tubules and mediates the efflux of cationic drugs. In the present study, the role of MATE1 in the nephrotoxicity of cisplatin was investigated in vivo and in vitro.
openaire  

Characterization of Drug-Drug Interactions for Remdesivir, an Intravenous Antiviral for SARS-CoV-2, in Healthy Participants. [PDF]

open access: yesClin Transl Sci
Chang J   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy